Impact of acute kidney injury in patients prescribed angiotensin-converting enzyme inhibitors over the first two years of life

被引:0
作者
Daishi Hirano
Saori Miwa
Daisuke Kakegawa
Chisato Umeda
Yoichi Takemasa
Ai Tokunaga
Kawakami Yuhei
Akira Ito
机构
[1] The Jikei University School of Medicine,Department of Pediatrics
[2] Saitama Children’s Medical Center,Division of Nephrology
来源
Pediatric Nephrology | 2021年 / 36卷
关键词
Acute kidney injury; KDIGO; Risk factor,; Down syndrome,; Tolvaptan; Pediatric medicine;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1907 / 1914
页数:7
相关论文
共 236 条
[1]  
Fox KM(2000)Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients N Engl J Med 342 145-153
[2]  
Hogg RJ(2003)Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study) Lancet 362 782-788
[3]  
Delucchi A(2007)A multicenter study of the pharmacokinetics of lisinopril in pediatric patients with hypertension Pediatr Nephrol 22 695-701
[4]  
Sakihara G(2006)ACE inhibitors in pediatric patients with heart failure Paediatr Drugs 8 55-69
[5]  
Wells TG(2005)Pharmacologic treatment of chronic pediatric hypertension Paediatr Drugs 7 27-40
[6]  
Tenney F(2008)Renin angiotensin system blockade and cardiovascular outcomes in patients with chronic kidney disease and proteinuria: a meta-analysis Am Heart J 155 791-805
[7]  
Batisky DL(2015)Comparative efficacy and safety of blood pressure-lowering agents in adults with diabetes and kidney disease: a network meta-analysis Lancet 385 2047-2056
[8]  
Blumer JL(1991)Reversible renal insufficiency due to angiotensin converting enzyme inhibitors in hypertensive nephrosclerosis Ann Intern Med 115 513-519
[9]  
Vogt BA(2000)Angiotensin-converting enzyme inhibitor-associated elevations in serum creatinine: is this a cause for concern? Arch Intern Med 160 685-693
[10]  
Lo MW(2011)An acute fall in estimated glomerular filtration rate during treatment with losartan predicts a slower decrease in long-term renal function Kidney Int 80 282-287